AU

AUNA

AUNAHealthcareNASDAQ

Medical Care Facilities

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$4.39B
-0.0% YoY
Net Income
$97.6M
-11.5% YoY
EBITDA
$856.7M
-3.4% YoY
Free Cash Flow
$315.0M

Scan Results

Daily timeframe
DateIndicatorDetails
Sep 2 Above MA150+0.6% from MA150, price crossed above
Sep 1 Above MA150+1.0% from MA150, price crossed above
About AUNA

AUNA operates in the Medical Care Facilities space. Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. With a market capitalization of $391.0M, it sits in small-cap territory. The company provides prepaid healthcare; dental and vision insurance; and oncology plans.

Where AUNA stands vs its 150-day and 200-day moving averages

As of the September 2, 2026 close, AUNA finished 0.59% above its 150-day moving average ($5.12) and 1.98% above its 200-day moving average ($5.05). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is AUNA overbought or oversold?

At the September 2, 2026 close, AUNA's RSI(14) was 47.1, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$391.0M
P/E (TTM)88.00
Fwd P/E4.78
EPS$0.06
Beta0.62
52W Change-17.0%
ROE1.6%
Analysis

On the balance sheet, AUNA has $481.3M in cash with $3.80B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company generates $315.0M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 1.6% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 5.2% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $2.45B (2022) to $4.39B (2025), reflecting a 79% increase over the period.

The relatively low beta of 0.62 suggests AUNA is a less volatile holding compared to the broader index. AUNA carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. The elevated P/E ratio means the stock is priced for significant future growth. If earnings disappoint, the price correction could be sharp. No single metric tells the full story. Reviewing AUNA's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms